Stay updated on Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.

Latest updates to the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page
- Check2 days agoChange DetectedThe history page now includes a glossary, color-coded change indicators (green for additions and red for deletions), and updated revision notes showing Revision: v3.4.0 (replacing v3.3.4). It also updates the No FEAR Act Data references accordingly.SummaryDifference0.3%

- Check9 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 in the page history. No other content changes are visible.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded Revision: v3.3.3 to the record history and removed HHS Vulnerability Disclosure and Revision: v3.3.2; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRecord History page now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page history shows an addition of Revision: v3.3.1 and deletion of Revision: v3.2.0, which appear to be internal revision log updates rather than user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedNotice about government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.